Literature DB >> 19775862

Differences in the use of pain coping strategies between oncology inpatients with mild vs. moderate to severe pain.

Inger Utne1, Christine Miaskowski, Kristin Bjordal, Steven M Paul, Gunnhild Jakobsen, Tone Rustøen.   

Abstract

The purposes of this study were to determine a clinically significant cutpoint for worst pain and to evaluate for differences in the use of pain coping strategies between oncology inpatients with mild (i.e., worst pain intensity scores of <or=4) compared with moderate to severe (i.e., worst pain intensity scores of >4) pain based on results of the cutpoint analysis. Oncology inpatients in pain (n=224) completed the Coping Strategies Questionnaire (CSQ), the Brief Pain Inventory, and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Fifty-six percent had moderate to severe pain. Patients in the moderate to severe pain group had significantly poorer Karnofsky Performance Status scores (P=0.04) and significantly lower ratings of overall health (P<0.0001). No differences were found between the two pain groups on any of the subscales of the CSQ, except catastrophizing (P<0.0001). Compared with the mild pain group, patients in the moderate to severe group scored significantly higher on this subscale. In addition, patients in the moderate to severe group used more passive coping strategies (P=0.02). Except for catastrophizing, the number and types of pain coping strategies used by this sample of hospitalized patients do not appear to be influenced by their pain intensity scores. Finally, when the CSQ scores of these hospitalized oncology patients were compared with those found in previous studies of oncology outpatients and patients with chronic noncancer pain, the scores were similar.

Entities:  

Mesh:

Year:  2009        PMID: 19775862     DOI: 10.1016/j.jpainsymman.2009.03.005

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  11 in total

1.  Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.

Authors:  Hiromichi Matsuoka; Satoru Iwase; Tempei Miyaji; Takashi Kawaguchi; Keisuke Ariyoshi; Shunsuke Oyamada; Eriko Satomi; Hiroto Ishiki; Hideaki Hasuo; Hiroko Sakuma; Akihiro Tokoro; Yoshinobu Matsuda; Kazuki Tahara; Hiroyuki Otani; Yoichi Ohtake; Hiroaki Tsukuura; Yoshihisa Matsumoto; Yoshikazu Hasegawa; Yuki Kataoka; Masatomo Otsuka; Kiyohiro Sakai; Miki Nakura; Tatsuya Morita; Takuhiro Yamaguchi; Atsuko Koyama
Journal:  Support Care Cancer       Date:  2019-11-25       Impact factor: 3.603

2.  Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer.

Authors:  Stephanie Gilbertson-White; Grace Campbell; Sandra Ward; Paula Sherwood; Heidi Donovan
Journal:  Cancer Nurs       Date:  2017 Mar/Apr       Impact factor: 2.592

3.  Pain Catastrophizing and EEG-α Asymmetry.

Authors:  Mark P Jensen; Ann Gianas; Leslie H Sherlin; Jon D Howe
Journal:  Clin J Pain       Date:  2015-10       Impact factor: 3.442

4.  Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery.

Authors:  Birha McCann; Christine Miaskowski; Theresa Koetters; Christina Baggott; Claudia West; Jon D Levine; Charles Elboim; Gary Abrams; Deborah Hamolsky; Laura Dunn; Hope Rugo; Marylin Dodd; Steven M Paul; John Neuhaus; Bruce Cooper; Brian Schmidt; Dale Langford; Janine Cataldo; Bradley E Aouizerat
Journal:  J Pain       Date:  2012-04-18       Impact factor: 5.820

5.  Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery.

Authors:  Christine Miaskowski; Bruce Cooper; Steven M Paul; Claudia West; Dale Langford; Jon D Levine; Gary Abrams; Deborah Hamolsky; Laura Dunn; Marylin Dodd; John Neuhaus; Christina Baggott; Anand Dhruva; Brian Schmidt; Janine Cataldo; John Merriman; Bradley E Aouizerat
Journal:  J Pain       Date:  2012-12       Impact factor: 5.820

6.  Pain Catastrophizing and Its Relationship with Health Outcomes: Does Pain Intensity Matter?

Authors:  Carlos Suso-Ribera; Azucena García-Palacios; Cristina Botella; Maria Victoria Ribera-Canudas
Journal:  Pain Res Manag       Date:  2017-02-28       Impact factor: 3.037

7.  Pain Beliefs and Perceptions and Their Relationship with Coping Strategies, Stress, Anxiety, and Depression in Patients with Cancer.

Authors:  Elahe Ramezanzade Tabriz; Reza Mohammadi; Gholam Reza Roshandel; Razieh Talebi
Journal:  Indian J Palliat Care       Date:  2019 Jan-Mar

8.  Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.

Authors:  Hiromichi Matsuoka; Hiroto Ishiki; Satoru Iwase; Atsuko Koyama; Takashi Kawaguchi; Yoshiyuki Kizawa; Tatsuya Morita; Yoshinobu Matsuda; Tempei Miyaji; Keisuke Ariyoshi; Takuhiro Yamaguchi
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

9.  Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).

Authors:  Hiromichi Matsuoka; Junji Tsurutani; Yasutaka Chiba; Yoshihiko Fujita; Masato Terashima; Takeshi Yoshida; Kiyohiro Sakai; Yoichi Otake; Atsuko Koyama; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  BMC Cancer       Date:  2017-10-06       Impact factor: 4.430

10.  A behavioral medicine intervention for community-dwelling older adults with chronic musculoskeletal pain: protocol for a randomized controlled trial.

Authors:  Sara Cederbom; Eva Denison; Astrid Bergland
Journal:  J Pain Res       Date:  2017-04-10       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.